Nuvation Bio Inc Class A (NUVB)
R&D Expenses
$30.66M
Quarterly · Period ending: · USD
NUVB R&D Expenses
Latest reported$30.66Mperiod ending
Latest reported$30.66Mperiod ending
NUVB Quarterly R&D Expenses ($6.14M → $30.66M)
Quarterly R&D Expenses
High-resolution chart · PNG
NUVB r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 30,661,000 | |
| 35,047,000 | |
| 34,297,000 | |
| 28,846,000 | |
| 27,362,000 | |
| 24,601,000 | |
| 29,299,000 | |
| 27,731,000 | |
| 454,317,000 | |
| 12,842,000 | |
| 15,351,000 | |
| 18,561,000 | |
| 18,590,000 | |
| 18,787,000 | |
| 16,871,000 | |
| 21,294,000 | |
| 28,922,000 | |
| 20,729,000 | |
| 22,002,000 | |
| 17,122,000 | |
| 14,034,000 | |
| 15,879,000 | |
| 9,336,000 | |
| 8,627,000 | |
| 7,345,000 | |
| 7,295,000 | |
| 8,800,000 | |
| 4,036,000 | |
| 6,135,000 | |
| 6,135,000 |